Generic Viagra’s absence stems primarily from Pfizer’s patent protection, which lasted until 2017 in the US. This exclusive manufacturing right prevented other companies from producing and selling chemically equivalent versions of sildenafil citrate, Viagra’s active ingredient.
However, patent expiration doesn’t automatically equate to immediate generic availability. Manufacturing generic drugs requires rigorous testing and FDA approval to confirm bioequivalence – proving they work the same way as the branded drug. This process, often lengthy and costly, explains the delay in generic Viagra’s widespread appearance.
Furthermore, several companies now offer sildenafil citrate under different brand names. These are not technically “generic Viagra,” but they provide the same active ingredient at lower prices than Pfizer’s branded product. You can find various options based on price and availability.
Finally, consider consulting your physician. They can advise you on appropriate treatment for erectile dysfunction, possibly including sildenafil citrate or alternative medications, ensuring you receive safe and effective care tailored to your specific needs. Don’t self-medicate; professional guidance is key.
